Description

According to StrategyHelix, the global surgical equipment market is expected to increase by US$ 10.5 billion during 2022-2028, expanding at a CAGR of 7.2% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for surgical equipment. The global surgical equipment market is segmented on the basis of category, technology, usability, and region. Based on category, the global surgical equipment market is categorized into cardiovascular, laparoscopy, microvascular surgery, neurosurgery, obstetrics & gynecology, orthopedic surgery, plastic & reconstructive, power systems, retractors, thoracic surgery, urology, wound closure, others. The laparoscopy segment captured the largest share of the market in 2021. On the basis of technology, the global surgical equipment market has been segmented into manual, electrosurgical, wireless. By usability, the global surgical equipment market has been segmented into disposable surgical equipment, reusable surgical equipment. In 2021, the reusable surgical equipment segment made up the largest share of revenue generated by the surgical equipment market. Geographically, the global surgical equipment market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global surgical equipment market is highly competitive. The report also includes the profiles of leading companies such as Aesculap Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Hologic Inc., Johnson & Johnson, Medtronic plc, Olympus Corp., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc. Competitive landscape gives a description of the competitive nature of the global surgical equipment market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the surgical equipment market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Category: cardiovascular, laparoscopy, microvascular surgery, neurosurgery, obstetrics & gynecology, orthopedic surgery, plastic & reconstructive, power systems, retractors, thoracic surgery, urology, wound closure, others
Technology: manual, electrosurgical, wireless
Usability: disposable surgical equipment, reusable surgical equipment
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Aesculap Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Hologic Inc., Johnson & Johnson, Medtronic plc, Olympus Corp., Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global surgical equipment market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Surgical equipment market overview
Part 3. Market breakdown by category
– Cardiovascular
– Laparoscopy
– Microvascular surgery
– Neurosurgery
– Obstetrics & gynecology
– Orthopedic surgery
– Plastic & reconstructive
– Power systems
– Retractors
– Thoracic surgery
– Urology
– Wound closure
– Others
Part 4. Market breakdown by technology
– Manual
– Electrosurgical
– Wireless
Part 5. Market breakdown by usability
– Disposable surgical equipment
– Reusable surgical equipment
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Aesculap, Inc.
– B. Braun Melsungen AG
– Becton, Dickinson and Company
– Boston Scientific Corporation
– CONMED Corporation
– Hologic Inc.
– Johnson & Johnson
– Medtronic plc
– Olympus Corp.
– Smith & Nephew plc
– Stryker Corporation
– Zimmer Biomet Holdings, Inc.
About StrategyHelix
Disclaimer